Abstract:The last decade has witnessed the growing development of optical imaging using near-infrared (NIR) light (wavelength range: 700–1700 nm) in a wide range of applications, from fundamental research of live biological and physiological processes to clinical applications such as disease screening and image-guide surgical interventions. The low-energy NIR light offers reduced tissue scattering, absorption as well as autofluorescence background compared to traditional wavelengths in the visible (400–700 nm) range, thus dramatically enhancing imaging resolution, signal-to-noise ratio, and penetration depth. This Research Topic calls for advances in new fluorescent probes, imaging instrumentation, analytical methods and their applications for improvement of diagnosis and therapy in this “tissue transparent window,” aiming to provide a timely update of this continuously evolving filed. Imaging and diagnosis agents are the cornerstone of preclinical applications. In their study, Tan et al. report lycosin-I peptide modified gold nanoclusters (LGNCs), which exhibit strong NIR fluorescence, for imaging of specific cancer cell nuclei. The lycosin-I peptide not only possesses highly efficient and selective intracellular translocation against several cancer cells, but also induces aggregation of gold nanoclusters to further enhance their brightness. After uptake by tumor cells, the LGNCs aggregates can be depolymerized into ultrasmall nanoclusters by the high level GSH in the tumor microenvironment, facilitating nuclear targeting translocation in cancer cells. Another study by Huang et al. reports a novel biomimetic nanoprobe for photoacoustic (PA) imaging of cervical carcinoma. This probe is constructed by coating indocyanine green (ICG)-loaded mesoporous silica nanoparticles with the cancer cell membrane, providing small particle size, excellent dispersion, large loading efficiency, good biocompatibility and homologous targeting ability to Hela cells in vitro. The biomimetic nanoprobe can specifically accumulate into tumor and display a superior PA imaging efficacy compared with free ICG, allowing for non-invasive deep tissue imaging of cervical carcinoma in vivo. Another article by Gu et al. focuses on a particular type of NIR fluorophores, semiconducting polymer nanoparticles (SPNs). SPNs are constructed by encapsulating hydrophobic semiconducting polymers (SPs) with amphiphilic copolymers, and have shown great promise for phototheranostics of cancer. The authors review recent advances of thiadiazoloquinoxaline (TQ)-based SPNs from their synthesis and hydrophilic functionalization to NIR-II (1,000–1,700 nm) fluorescence imagingguided cancer photothermal therapy (PTT). To enhance the PTT efficiency, they also discuss methods for constructing SPNs with capability of multimodal imaging. Current limitations are summarized at the end that hamper clinical applications of the SPNs, such as relatively large size and low tumor targeting ability. Edited and reviewed by: Gianni Ciofani, Italian Institute of Technology (IIT), Italy

Highly Bright Near-Infrared Chemiluminescent Probes for Cancer Imaging and Laparotomy.

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Near-Infrared Unimolecular Chemiluminescence Probes for Deep-Tissue Imaging

Smart On-Site Immobilizable Near-Infrared II Fluorescent Nanoprobes for Ultra-Long-Term Imaging-Guided Tumor Surgery and Photothermal Therapy

Catalytic NIR chemiluminescence sensor with enhanced persistence and intensity for in vivo imaging

Building Highly Light‐Harvesting Near‐Infrared AIEgens Using Triazole‐Based Luminescent Core for Improved Intravital Afterglow Imaging

Near‐Infrared Persistent Luminescence Nanoprobe for Ultrasensitive Image‐Guided Tumor Resection

Near‐Infrared AIE Dots with Chemiluminescence for Deep‐Tissue Imaging

Organic NIR‐II Nanofluorophore with Ultrahigh Quantum Yield for Vessels Imaging and Fluorescence Image‐Guided Surgery

Molecular Engineering of Bright NIR-I/NIR-II Nanofluorophores for High-Resolution Bioimaging and Tumor Detection in Vivo.

Discovery of Near-Infrared Heptamethine Cyanine Probes for Imaging-Guided Surgery in Solid Tumors

Near‐Infrared Chemiluminophore Switches Photodynamic Processes via Protein Complexation for Biomarker‐Activatable Cancer Therapy

Selective Imaging and Cancer Cell Death Via Ph Switchable Near-Infrared Fluorescence and Photothermal Effects.

A Novel Luminescent Ir(iii) Complex for Dual Mode Imaging: Synergistic Response to Hypoxia and Acidity of the Tumor Microenvironment

Editorial: Precise Diagnosis and Therapy Using Near-Infrared Light

Hierarchically Nanostructured Hybrid Platform for Tumor Delineation and Image-Guided Surgery Via NIR-II Fluorescence and PET Bimodal Imaging.

1,2‐Dioxetane‐based Chemiluminescence Probes for Tumor Optical Molecular Imaging

Bright Near-Infrared Aggregation-Induced Emission Dots For Long-Term Bioimaging In Vitro/Vivo

Preparation of Near-infrared Photoacoustic Imaging and Photothermal Treatment Agent for Cancer Using a Modifiable Acid-triggered Molecular Platform

Precise tumor delineation in clinical tissues using a novel acidic tumor microenvironment activatable near-infrared fluorescent contrast agent

A Tandem‐Locked Chemiluminescent Probe for Imaging of Macrophage Polarization